reports
iRhythm Technologies to Report First Quarter 2024 Financial Results on...
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the presentation...
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Seni...
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the closing of its offering of 1.50% Convertible Senior Notes due 2029 (the “notes”) for gross proceeds of $661.25 million in a private placement to persons reasona...
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible...
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the pricing of its offering of $575.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Secu...
iRhythm Announces Proposed Offering of $450.0 Million of Convertible S...
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and help prevent disease, announced today that it intends to offer, subject to market conditions and other factors, $450.0 million aggregate principal amount of Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to...
iRhythm collaborates with Epic to streamline access to Zio® service an...
iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients iRhythm is the first medical device company to join the Epic community, using Aura to drive efficiencies through EHR integrationThe collaboration will expand access to Zio service across the continuum of patient care—from cardiology to primary care to emergency departments and beyond1 SAN FRANCISCO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital healthcare company focused on creating trusted solutions that detect, predict, and preve...
iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Finan...
iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Grew fourth quarter 2023 patient registrations in excess of 22% compared to the fourth quarter 2022Revenue of $132.5 million, a 17.7% increase compared to fourth qua...
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Finan...
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2023 after the close of trading on Thursday, February 22, 2024. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live...
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights...
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 42nd Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Grew fourth quarter 2023 patient registrations in excess of 22%...
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitorin...
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service Findings published in the American Heart Journal show higher clinical diagnostic yield and lower odds of retesting with Zio long-term continuous monitoring service (LTCM) compared to other LTCM and ambulatory cardiac monitoring (ACM) productsLTCM was associated with lower incremental health care utilization and cost SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) today announced that the results from the Cardia...
iRhythm Technologies reçoit le marquage CE en vertu du règlement relat...
iRhythm Technologies reçoit le marquage CE en vertu du règlement relatif aux dispositifs médicaux (règlement UE relatif aux DM) pour son moniteur Zio® et son système ZEUS Le marquage CE renforce le statut du système de surveillance Zio en tant qu’innovation de pointe en matière de surveillance cardiaque ambulatoire et souligne l’engagement de la société à fournir des produits et services de la plus haute qualité à l’échelle mondiale. SAN FRANCISCO, 04 janv. 2024 (GLOBE NEWSWIRE) -- (NASDAQ : IRTC), une société leader dans le domaine des soins de santé numériques qui contribue à créer d...
iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union ge...
iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System Die CE-Kennzeichnung unterstreicht die führende Rolle des Zio-Monitorsystems bei der ambulanten Herzüberwachung und unterstreicht das Engagement des Unternehmens, weltweit Produkte und Dienstleistungen von höchster Qualität anzubieten SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), ein führendes Unternehmen im Bereich der digitalen Gesundheit, das sich auf die Entwicklung zuverlässiger Lösungen zur Erkennung, Vorhersage und Vorbeu...
iRhythm Technologies Receives European Union’s CE Marking Under Medica...
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally SAN FRANCISCO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that its next generation long-term ambulatory cardiac m...
New Research Presented at American Heart Association’s 2023 Scientific...
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization Study findings from a collaboration with Duke Health found that a model that incorporates ECG data from long-term continuous monitoring resulted in more accurate prediction of heart failure hospitalization compared to clinical risk models SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of a new retrospective analysis, conduct...
iRhythm Technologies Announces Third Quarter 2023 Financial Results
iRhythm Technologies Announces Third Quarter 2023 Financial Results SAN FRANCISCO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three and nine months ended September 30, 2023. Third Quarter 2023 Financial Highlights Revenue of $124.6 million, a 20.0% increase compared to third quarter 2022Gross margin of 66.2%, a 210-basis point decline compared to third quarter 2022Cash, cash equivalents and marketable securities of $158.5...
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
CEM CLEARBRIDGE ENERGY MLP FUND INC.
RMAX RE/MAX HOLDINGS INC.
OXBR OXBRIDGE RE HOLDINGS
NTRS NORTHERN TRUST CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
DG DOLLAR GENERAL CORPORATION
CTRN CITI TRENDS INC.
COTY COTY INC. CLASS A
BLFS BIOLIFE SOLUTIONS INC
ALDX ALDEYRA THERAPEUTICS
ASA ASA
PESI PERMA-FIX ENVIRONMENTAL SERVICES INC.
SHW SHERWIN-WILLIAMS COMPANY
QRHC QUEST RESOURCE HOLDING
ADC AGREE REALTY CORPORATION
CCL CARNIVAL CORPORATION
POH3 CARNIVAL PLC
PAGP PLAINS GP HOLDINGS LP CLASS A
AGX ARGAN INC.
PTGX PROTAGONIST THERAPEUTICS
ASTI ASCENT SOLAR TECHNOLOGIES
MHI INC.
AXR PIONEER MUNICIPAL HIGH INCOME TRUST
BCEL AMREP
SCU ATRECA
RMBI SCULPTOR CAPITAL MANAGEMENT INC (A)
CAPR RICHMOND MUTUAL BANCORPORATION
GLT INC.
CERE CAPRICOR THERAPEUTICS
AVO GLATFELTER CORPORATION
PUBM CEREVEL THERAPEUTICS HOLDINGS (A)
IMNM MISSION PRODUCE
GNSS PUBMATIC
RBLX IMMUNOME
CYTH GENASYS INC
SMMT ROBLOX
ME CYCLO THERAPEUTICS
ATXS SUMMIT THERAPEUTICS INC
ERAS 23ANDME HOLDING CO.
GAIA ASTRIA THERAPEUTICS INC
EMO ERASCA INC
BHVN GAIA GROW CORP
BANX CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
BIOHAVEN LTD
STONECASTLE FINANCIAL CORP.
- Jonathan Moreland
iRhythm Technologies to Report Third Quarter 2023 Financial Results on...
iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023 SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2023 after the close of trading on Thursday, November 2, 2023. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Investors interested in listening to the conference call may do so b...
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service:...
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.Zio® monitor builds on the high performance of Zio® XT that, together with its enhanced Zio® long term continuous cardiac monitoring service, provides an elevated end-to-end experienceZio monitor demonstrates high 99% patient compliance with prescribed wear times1 SAN FRANCISCO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) today announced the U.S. launch of its nex...
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
DXCM DEXCOM INC.
PPG PPG INDUSTRIES INC.
CNHI CNH INDUSTRIAL NV
UCTT ULTRA CLEAN HOLDINGS INC.
QYM SOCIEDAD QUIMICA Y MINERA DE CHILE S.A. SERIES B ADS
SLAB SILICON LABORATORIES INC.
SEE SEALED AIR CORPORATION
SEDG SOLAREDGE TECHNOLOGIES INC.
SCL STEPAN COMPANY
RVNC REVANCE THERAPEUTICS INC.
PODD INSULET CORPORATION
MKSI MKS INSTRUMENTS INC.
MIDD MIDDLEBY CORPORATION
LGIH LGI HOMES INC.
HUN HUNTSMAN CORPORATION
HII HUNTINGTON INGALLS INDUSTRIES INC.
FELE FRANKLIN ELECTRIC CO. INC.
DIOD DIODES INCORPORATED
DGII DIGI INTERNATIONAL INC.
CSIQ CANADIAN SOLAR INC.
COO COOPER COMPANIES INC.
CMP COMPASS MINERALS INTERNATIONAL INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
B BARNES GROUP INC.
AMBA AMBARELLA INC.
ALNY ALNYLAM PHARMACEUTICALS INC
ALB ALBEMARLE CORPORATION
MHK MOHAWK INDUSTRIES INC.
ERII ENERGY RECOVERY INC.
HPQ HP INC.
CG. CENTERRA GOLD INC.
FR. FIRST MAJESTIC SILVER CORP.
DOOR MASONITE INTERNATIONAL CORP.
LEG LEG IMMOBILIEN AG
ELY CALLAWAY GOLF COMPANY
FMC FMC CORPORATION
JKS JINKOSOLAR HOLDING CO. LTD. SPONSORED ADR
KMT KENNAMETAL INC.
TTC TORO COMPANY
XYL XYLEM INC.
AOS A. O. SMITH CORPORATION
ASIX ADVANSIX INC.
NOVT NOVANTA INC
SNDX SYNDAX PHARMACEUTICALS
IRTC IRHYTHM TECHNOLOGIES INC.
ASML ASML HOLDING N.V.
LTHM LIVENT
HROW HARROW HEALTH INC.
KROS KEROS THERAPEUTICS
MP MP MATERIALS CORP (A)
ALGM ALLEGRO MICROSYSTEMS
OI O-I GLASS INC
WOLF WOLFSPEED INC
TGI TGI INFRASTRUCTURES LTD
iRhythm Technologies to Participate in Two Investor Conferences in Sep...
iRhythm Technologies to Participate in Two Investor Conferences in September SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the Company will be participating in the upcoming Baird 2023 Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference. iRhythm’s management is scheduled to present at Baird’s 2023 Global Healthcare Conference on Tuesday, September 12, at 9:05 am Eastern Time and at the Morgan...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.